{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:06:18Z","timestamp":1793196378538,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"8025","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2024,8,15]]},"DOI":"10.1038\/s41586-024-07804-3","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T16:14:48Z","timestamp":1723047288000},"page":"678-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Structure of the human dopamine transporter in complex with cocaine"],"prefix":"10.1038","volume":"632","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0678-3689","authenticated-orcid":false,"given":"Jeppe C.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2170-7147","authenticated-orcid":false,"given":"Kristine","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris E.","family":"Kalenderoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bargmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0612-3568","authenticated-orcid":false,"given":"Tillmann","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5405-597X","authenticated-orcid":false,"given":"Azadeh","family":"Shahsavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1773-1446","authenticated-orcid":false,"given":"Claus J.","family":"Loland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"7804_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B Giros","year":"1996","unstructured":"Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606\u2013612 (1996).","journal-title":"Nature"},{"key":"7804_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1124\/pr.108.000869","volume":"63","author":"AS Kristensen","year":"2011","unstructured":"Kristensen, A. S. et al. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol. Rev. 63, 585\u2013640 (2011).","journal-title":"Pharmacol. Rev."},{"key":"7804_CR3","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.1073\/pnas.0600905103","volume":"103","author":"R Chen","year":"2006","unstructured":"Chen, R. et al. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc. Natl Acad. Sci. USA 103, 9333\u20139338 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7804_CR4","doi-asserted-by":"publisher","first-page":"15340","DOI":"10.3390\/ijms242015340","volume":"24","author":"SE Davis","year":"2023","unstructured":"Davis, S. E., Cirincione, A. B., Jimenez-Torres, A. C. & Zhu, J. The impact of neurotransmitters on the neurobiology of neurodegenerative diseases. Int. J. Mol. Sci. 24, 15340 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"7804_CR5","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1073\/pnas.95.7.4029","volume":"95","author":"SR Jones","year":"1998","unstructured":"Jones, S. R. et al. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl Acad. Sci. USA 95, 4029\u20134034 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7804_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature14431","volume":"521","author":"KH Wang","year":"2015","unstructured":"Wang, K. H., Penmatsa, A. & Gouaux, E. Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature 521, 322\u2013327 (2015).","journal-title":"Nature"},{"key":"7804_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature12533","volume":"503","author":"A Penmatsa","year":"2013","unstructured":"Penmatsa, A., Wang, K. H. & Gouaux, E. X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503, 85\u201390 (2013).","journal-title":"Nature"},{"key":"7804_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25363-3","volume":"12","author":"P Plenge","year":"2021","unstructured":"Plenge, P. et al. The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter. Nat. Commun. 12, 5063 (2021).","journal-title":"Nat. Commun."},{"key":"7804_CR9","doi-asserted-by":"publisher","first-page":"eabl3857","DOI":"10.1126\/sciadv.abl3857","volume":"7","author":"D Yang","year":"2021","unstructured":"Yang, D. & Gouaux, E. Illumination of serotonin transporter mechanism and role of the allosteric site. Sci. Adv. 7, eabl3857 (2021).","journal-title":"Sci. Adv."},{"key":"7804_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nature17629","volume":"532","author":"JA Coleman","year":"2016","unstructured":"Coleman, J. A., Green, E. M. & Gouaux, E. X-ray structures and mechanism of the human serotonin transporter. Nature 532, 334\u2013339 (2016).","journal-title":"Nature"},{"key":"7804_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41586-021-03274-z","volume":"591","author":"A Shahsavar","year":"2021","unstructured":"Shahsavar, A. et al. Structural insights into the inhibition of glycine reuptake. Nature 591, 677\u2013681 (2021).","journal-title":"Nature"},{"key":"7804_CR12","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2024.02.026","volume":"187","author":"Y Wei","year":"2024","unstructured":"Wei, Y. et al. Transport mechanism and pharmacology of the human GlyT1. Cell 187, 1719\u20131732 (2024).","journal-title":"Cell"},{"key":"7804_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41586-022-04814-x","volume":"606","author":"Z Motiwala","year":"2022","unstructured":"Motiwala, Z. et al. Structural basis of GABA reuptake inhibition. Nature 606, 820\u2013826 (2022).","journal-title":"Nature"},{"key":"7804_CR14","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41594-023-01011-w","volume":"30","author":"SR Nayak","year":"2023","unstructured":"Nayak, S. R. et al. Cryo-EM structure of GABA transporter 1 reveals substrate recognition and transport mechanism. Nat. Struct. Mol. Biol. 30, 1023\u20131032 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"7804_CR15","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41594-023-00983-z","volume":"30","author":"A Zhu","year":"2023","unstructured":"Zhu, A. et al. Molecular basis for substrate recognition and transport of human GABA transporter GAT1. Nat. Struct. Mol. Biol. 30, 1012\u20131022 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"7804_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature03978","volume":"437","author":"A Yamashita","year":"2005","unstructured":"Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na+\/Cl\u2212-dependent neurotransmitter transporters. Nature 437, 215\u2013223 (2005).","journal-title":"Nature"},{"key":"7804_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.bbagen.2014.04.011","volume":"1850","author":"CJ Loland","year":"2015","unstructured":"Loland, C. J. The use of LeuT as a model in elucidating binding sites for substrates and inhibitors in neurotransmitter transporters. Biochim. Biophys. Acta 1850, 500\u2013510 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"7804_CR18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1085\/jgp.201812066","volume":"151","author":"G Rudnick","year":"2019","unstructured":"Rudnick, G. & Sandtner, W. Serotonin transport in the 21st century. J. Gen. Physiol. 151, 1248\u20131264 (2019).","journal-title":"J. Gen. Physiol."},{"key":"7804_CR19","doi-asserted-by":"publisher","first-page":"25764","DOI":"10.1074\/jbc.M114.574269","volume":"289","author":"L Borre","year":"2014","unstructured":"Borre, L., Andreassen, T. F., Shi, L., Weinstein, H. & Gether, U. The second sodium site in the dopamine transporter controls cation permeation and is regulated by chloride. J. Biol. Chem. 289, 25764\u201325773 (2014).","journal-title":"J. Biol. Chem."},{"key":"7804_CR20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.692012","author":"S Tavoulari","year":"2016","unstructured":"Tavoulari, S. et al. Two Na+ sites control conformational change in a neurotransmitter transporter homolog. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.M115.692012 (2016).","journal-title":"J. Biol. Chem."},{"key":"7804_CR21","doi-asserted-by":"publisher","first-page":"10084","DOI":"10.1016\/S0021-9258(19)86675-9","volume":"254","author":"PJ Nelson","year":"1979","unstructured":"Nelson, P. J. & Rudnick, G. Coupling between platelet 5-hydroxytryptamine and potassium transport. J. Biol. Chem. 254, 10084\u201310089 (1979).","journal-title":"J. Biol. Chem."},{"key":"7804_CR22","doi-asserted-by":"publisher","first-page":"e2319384121","DOI":"10.1073\/pnas.2319384121","volume":"121","author":"E Hellsberg","year":"2024","unstructured":"Hellsberg, E. et al. Identification of the potassium-binding site in serotonin transporter. Proc. Natl Acad. Sci. USA 121, e2319384121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7804_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30154-5","volume":"13","author":"SG Schmidt","year":"2022","unstructured":"Schmidt, S. G. et al. The dopamine transporter antiports potassium to increase the uptake of dopamine. Nat. Commun. 13, 2446 (2022).","journal-title":"Nat. Commun."},{"key":"7804_CR24","doi-asserted-by":"publisher","first-page":"e67996","DOI":"10.7554\/eLife.67996","volume":"10","author":"S Bhat","year":"2021","unstructured":"Bhat, S. et al. Handling of intracellular K+ determines voltage dependence of plasmalemmal monoamine transporter function. eLife 10, e67996 (2021).","journal-title":"eLife"},{"key":"7804_CR25","doi-asserted-by":"publisher","first-page":"e1005907","DOI":"10.1371\/journal.pcbi.1005907","volume":"14","author":"T Zeppelin","year":"2018","unstructured":"Zeppelin, T., Ladefoged, L. K., Sinning, S., Periole, X. & Schiott, B. A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition. PLoS Comput. Biol. 14, e1005907 (2018).","journal-title":"PLoS Comput. Biol."},{"key":"7804_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22385-9","volume":"12","author":"S Pidathala","year":"2021","unstructured":"Pidathala, S., Mallela, A. K., Joseph, D. & Penmatsa, A. Structural basis of norepinephrine recognition and transport inhibition in neurotransmitter transporters. Nat. Commun. 12, 2199 (2021).","journal-title":"Nat. Commun."},{"key":"7804_CR27","first-page":"83","volume":"59","author":"P P\u00f6rzgen","year":"2001","unstructured":"P\u00f6rzgen, P., Park, S. K., Hirsh, J., Sonders, M. S. & Amara, S. G. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines. Mol. Pharmacol. 59, 83\u201395 (2001).","journal-title":"Mol. Pharmacol."},{"key":"7804_CR28","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.3390\/cells11233811","volume":"11","author":"CF Pugh","year":"2022","unstructured":"Pugh, C. F., DeVree, B. T., Schmidt, S. G. & Loland, C. J. Pharmacological characterization of purified full-length dopamine transporter from Drosophila melanogaster. Cells 11, 3811 (2022).","journal-title":"Cells"},{"key":"7804_CR29","doi-asserted-by":"publisher","first-page":"e2304602120","DOI":"10.1073\/pnas.2304602120","volume":"120","author":"D Yang","year":"2023","unstructured":"Yang, D., Zhao, Z., Tajkhorshid, E. & Gouaux, E. Structures and membrane interactions of native serotonin transporter in complexes with psychostimulants. Proc. Natl Acad. Sci. USA 120, e2304602120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7804_CR30","doi-asserted-by":"publisher","first-page":"9485","DOI":"10.1002\/chem.201200069","volume":"18","author":"PS Chae","year":"2012","unstructured":"Chae, P. S. et al. A new class of amphiphiles bearing rigid hydrophobic groups for solubilization and stabilization of membrane proteins. Chemistry 18, 9485\u20139490 (2012).","journal-title":"Chemistry"},{"key":"7804_CR31","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1523\/JNEUROSCI.1863-04.2004","volume":"24","author":"C Bjerggaard","year":"2004","unstructured":"Bjerggaard, C. et al. Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions. J. Neurosci. 24, 7024\u20137036 (2004).","journal-title":"J. Neurosci."},{"key":"7804_CR32","doi-asserted-by":"publisher","first-page":"21012","DOI":"10.1074\/jbc.M311972200","volume":"279","author":"LB Li","year":"2004","unstructured":"Li, L. B. et al. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279, 21012\u201321020 (2004).","journal-title":"J. Biol. Chem."},{"key":"7804_CR33","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/mp.2017.176","volume":"22","author":"J Garcia-Olivares","year":"2017","unstructured":"Garcia-Olivares, J. et al. G\u03b2\u03b3 subunit activation promotes dopamine efflux through the dopamine transporter. Mol. Psychiatry 22, 1673\u20131679 (2017).","journal-title":"Mol. Psychiatry"},{"key":"7804_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.neuron.2006.06.028","volume":"51","author":"JU Fog","year":"2006","unstructured":"Fog, J. U. et al. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417\u2013429 (2006).","journal-title":"Neuron"},{"key":"7804_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nn.2781","volume":"14","author":"ML Cremona","year":"2011","unstructured":"Cremona, M. L. et al. Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT. Nat. Neurosci. 14, 469\u2013477 (2011).","journal-title":"Nat. Neurosci."},{"key":"7804_CR36","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1021\/acschembio.0c00316","volume":"15","author":"M Ehsan","year":"2020","unstructured":"Ehsan, M. et al. New malonate-derived tetraglucoside detergents for membrane protein stability. ACS Chem. Biol. 15, 1697\u20131707 (2020).","journal-title":"ACS Chem. Biol."},{"key":"7804_CR37","doi-asserted-by":"publisher","first-page":"43694","DOI":"10.1074\/jbc.M112.342212","volume":"287","author":"L S\u00f8rensen","year":"2012","unstructured":"S\u00f8rensen, L. et al. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket. J. Biol. Chem. 287, 43694\u201343707 (2012).","journal-title":"J. Biol. Chem."},{"key":"7804_CR38","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1074\/jbc.M505055200","volume":"281","author":"LK Henry","year":"2006","unstructured":"Henry, L. K. et al. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. J. Biol. Chem. 281, 2012\u20132023 (2006).","journal-title":"J. Biol. Chem."},{"key":"7804_CR39","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nn.2146","volume":"11","author":"T Beuming","year":"2008","unstructured":"Beuming, T. et al. The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat. Neurosci. 11, 780\u2013789 (2008).","journal-title":"Nat. Neurosci."},{"key":"7804_CR40","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.str.2015.09.001","volume":"23","author":"MH Cheng","year":"2015","unstructured":"Cheng, M. H. & Bahar, I. Molecular mechanism of dopamine transport by human dopamine transporter. Structure 23, 2171\u20132181 (2015).","journal-title":"Structure"},{"key":"7804_CR41","doi-asserted-by":"publisher","first-page":"39316","DOI":"10.1074\/jbc.M112.371765","volume":"287","author":"P Plenge","year":"2012","unstructured":"Plenge, P. et al. Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter. J. Biol. Chem. 287, 39316\u201339326 (2012).","journal-title":"J. Biol. Chem."},{"key":"7804_CR42","doi-asserted-by":"publisher","first-page":"e2304089120","DOI":"10.1073\/pnas.2304089120","volume":"120","author":"K Salomon","year":"2023","unstructured":"Salomon, K. et al. Dynamic extracellular vestibule of human SERT: unveiling druggable potential with high-affinity allosteric inhibitors. Proc. Natl Acad. Sci. USA 120, e2304089120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7804_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15292-y","volume":"11","author":"P Plenge","year":"2020","unstructured":"Plenge, P. et al. The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter. Nat. Commun. 11, 1491 (2020).","journal-title":"Nat. Commun."},{"key":"7804_CR44","doi-asserted-by":"publisher","first-page":"e56427","DOI":"10.7554\/eLife.56427","volume":"9","author":"JA Coleman","year":"2020","unstructured":"Coleman, J. A. et al. Chemical and structural investigation of the paroxetine-human serotonin transporter complex. eLife 9, e56427 (2020).","journal-title":"eLife"},{"key":"7804_CR45","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1074\/jbc.M117.809046","volume":"293","author":"L Laursen","year":"2018","unstructured":"Laursen, L. et al. Cholesterol binding to a conserved site modulates the conformation, pharmacology, and transport kinetics of the human serotonin transporter. J. Biol. Chem. 293, 3510\u20133523 (2018).","journal-title":"J. Biol. Chem."},{"key":"7804_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10449-w","volume":"10","author":"AK Nielsen","year":"2019","unstructured":"Nielsen, A. K. et al. Substrate-induced conformational dynamics of the dopamine transporter. Nat. Commun. 10, 2714 (2019).","journal-title":"Nat. Commun."},{"key":"7804_CR47","doi-asserted-by":"publisher","first-page":"e2115435118","DOI":"10.1073\/pnas.2115435118","volume":"118","author":"JS Bloch","year":"2021","unstructured":"Bloch, J. S. et al. Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins. Proc. Natl Acad. Sci. USA 118, e2115435118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7804_CR48","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.str.2012.02.017","volume":"20","author":"S Wu","year":"2012","unstructured":"Wu, S. et al. Fabs enable single particle cryoEM studies of small proteins. Structure 20, 582\u2013592 (2012).","journal-title":"Structure"},{"key":"7804_CR49","doi-asserted-by":"publisher","first-page":"100863","DOI":"10.1016\/j.jbc.2021.100863","volume":"297","author":"E Esendir","year":"2021","unstructured":"Esendir, E. et al. Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding. J. Biol. Chem. 297, 100863 (2021).","journal-title":"J. Biol. Chem."},{"key":"7804_CR50","doi-asserted-by":"publisher","first-page":"6781","DOI":"10.1021\/acs.jmedchem.7b00057","volume":"60","author":"F Spyrakis","year":"2017","unstructured":"Spyrakis, F. et al. The roles of water in the protein matrix: a largely untapped resource for drug discovery. J. Med. Chem. 60, 6781\u20136827 (2017).","journal-title":"J. Med. Chem."},{"key":"7804_CR51","doi-asserted-by":"publisher","unstructured":"Okorom, A. V. et al. Modifications to 1-(4-(2-bis(4-fluorophenyl)methyl)sulfinyl)alkyl alicyclic amines that improve metabolic stability and retain an atypical DAT inhibitor profile. J. Med. Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c02037 (2024).","DOI":"10.1021\/acs.jmedchem.3c02037"},{"key":"7804_CR52","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1471-4159.2004.02386.x","volume":"89","author":"N Chen","year":"2004","unstructured":"Chen, N., Zhen, J. & Reith, M. E. A. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine. J. Neurochem. 89, 853\u2013864 (2004).","journal-title":"J. Neurochem."},{"key":"7804_CR53","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1523\/JNEUROSCI.16-17-05405.1996","volume":"16","author":"S Mager","year":"1996","unstructured":"Mager, S. et al. Ion binding and permeation at the GABA transporter GAT1. J. Neurosci. 16, 5405\u20135414 (1996).","journal-title":"J. Neurosci."},{"key":"7804_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-019-1135-1","volume":"569","author":"JA Coleman","year":"2019","unstructured":"Coleman, J. A. et al. Serotonin transporter\u2013ibogaine complexes illuminate mechanisms of inhibition and transport. Nature 569, 141\u2013145 (2019).","journal-title":"Nature"},{"key":"7804_CR55","doi-asserted-by":"publisher","first-page":"32616","DOI":"10.1074\/jbc.M110.150565","volume":"285","author":"WC Hong","year":"2010","unstructured":"Hong, W. C. & Amara, S. G. Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. J. Biol. Chem. 285, 32616\u201332626 (2010).","journal-title":"J. Biol. Chem."},{"key":"7804_CR56","doi-asserted-by":"publisher","first-page":"e202201708","DOI":"10.26508\/lsa.202201708","volume":"6","author":"ZJ Frangos","year":"2023","unstructured":"Frangos, Z. J. et al. Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2. Life Sci. Alliance 6, e202201708 (2023).","journal-title":"Life Sci. Alliance"},{"key":"7804_CR57","doi-asserted-by":"publisher","first-page":"eaar6179","DOI":"10.1126\/sciadv.aar6179","volume":"4","author":"PS Merkle","year":"2018","unstructured":"Merkle, P. S. et al. Substrate-modulated unwinding of transmembrane helices in the NSS transporter LeuT. Sci. Adv. 4, eaar6179 (2018).","journal-title":"Sci. Adv."},{"key":"7804_CR58","doi-asserted-by":"publisher","first-page":"10172","DOI":"10.1021\/acs.jmedchem.7b01454","volume":"60","author":"MF Zou","year":"2017","unstructured":"Zou, M. F. et al. Structure\u2013activity relationship studies on a series of 3\u03b1-[Bis(4-fluorophenyl)methoxy]tropanes and 3\u03b1-[Bis(4-fluorophenyl)methylamino]tropanes as novel atypical dopamine transporter (DAT) inhibitors for the treatment of cocaine use disorders. J. Med. Chem. 60, 10172\u201310187 (2017).","journal-title":"J. Med. Chem."},{"key":"7804_CR59","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","volume":"72","author":"CJ Loland","year":"2012","unstructured":"Loland, C. J. et al. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biol. Psychiatry 72, 405\u2013413 (2012).","journal-title":"Biol. Psychiatry"},{"key":"7804_CR60","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1124\/mol.107.039800","volume":"73","author":"CJ Loland","year":"2008","unstructured":"Loland, C. J. et al. Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol. Pharmacol. 73, 813\u2013823 (2008).","journal-title":"Mol. Pharmacol."},{"key":"7804_CR61","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"7804_CR62","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"7804_CR63","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"7804_CR64","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1021\/ja00299a024","volume":"107","author":"MJS Dewar","year":"1993","unstructured":"Dewar, M. J. S., Zoebisch, E. G., Healy, E. F. & Stewart, J. J. P. Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107, 3902\u20133909 (1985).","journal-title":"J. Am. Chem. Soc."},{"key":"7804_CR65","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"7804_CR66","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley, J. C. et al. Epik: a software program for pKa prediction and protonation state generation for drug-like molecules. J. Comput. Aided Mol. Des. 21, 681\u2013691 (2007).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"7804_CR67","doi-asserted-by":"publisher","first-page":"D370","DOI":"10.1093\/nar\/gkr703","volume":"40","author":"MA Lomize","year":"2012","unstructured":"Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I. & Lomize, A. L. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 40, D370\u2013D376 (2012).","journal-title":"Nucleic Acids Res."},{"key":"7804_CR68","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"7804_CR69","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12, 405\u2013413 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"7804_CR70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"7804_CR71","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1021\/jp101759q","volume":"114","author":"JB Klauda","year":"2010","unstructured":"Klauda, J. B. et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J. Phys. Chem. B 114, 7830\u20137843 (2010).","journal-title":"J. Phys. Chem. B"},{"key":"7804_CR72","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"7804_CR73","doi-asserted-by":"publisher","unstructured":"Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. https:\/\/doi.org\/10.1063\/1.2408420 (2007).","DOI":"10.1063\/1.2408420"},{"key":"7804_CR74","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/00268978300102851","volume":"50","author":"S Nos\u00e9","year":"1983","unstructured":"Nos\u00e9, S. & Klein, M. L. Constant pressure molecular dynamics for molecular systems. Mol. Phys. 50, 1055\u20131076 (1983).","journal-title":"Mol. Phys."},{"key":"7804_CR75","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"key":"7804_CR76","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1997).","journal-title":"J. Comput. Chem."},{"key":"7804_CR77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"7804_CR78","doi-asserted-by":"publisher","unstructured":"Nielsen, J. C. et al. MD simulations files for: structure of the human dopamine transporter in complex with cocaine. Zenodo https:\/\/doi.org\/10.5281\/zenodo.10804003 (2024).","DOI":"10.5281\/zenodo.10804003"}],"updated-by":[{"DOI":"10.1038\/s41586-025-08976-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07804-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07804-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07804-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T18:01:14Z","timestamp":1745776874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07804-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":78,"journal-issue":{"issue":"8025","published-print":{"date-parts":[[2024,8,15]]}},"alternative-id":["7804"],"URL":"https:\/\/doi.org\/10.1038\/s41586-024-07804-3","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"15 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-025-08976-2","URL":"https:\/\/doi.org\/10.1038\/s41586-025-08976-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}